The growing demand for controlled immunological study and therapeutic creation has spurred significant improvements in recombinant growth factor production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently manufactured using multiple expression platforms, including bacterial hosts, higher cell lines, and insect